Latin America Medical Oxygen Concentrators Market Size & Share 2024 – 2032

LATAM Medical Oxygen Concentrators Market Size

Latin America medical oxygen concentrators market size was valued at USD 100.7 million in 2023 and is expected to exhibit growth at a CAGR of 5.7% from 2024 to 2032. Medical oxygen concentrators deliver essential oxygen to patients with low saturation levels. Powered by batteries or plugs, these devices extract air, purify it, and then supply oxygen to the patient.

By eliminating impurities like nitrogen, they ensure a stream of oxygen-rich air. As respiratory disorders rise, the demand for these life-saving oxygen therapy systems is set to grow. High market growth can be attributed to the rising incidence of respiratory diseases, growing elderly population, technological advancements, and expanding healthcare infrastructure, among other contributing factors.

Moreover, the government's focus on enhancing healthcare infrastructure and expanding access to medical care has robustly contributed to the growth of medical oxygen concentrators market in the country. Government's initiatives, such as the National Health and Wellness Plan, aim to improve the management of chronic respiratory diseases, especially in rural and underserved areas. For instance, during and after the COVID-19 pandemic, the Mexican government launched several campaigns to ensure the availability of oxygen concentrators for patients with respiratory complications, leading to a substantial increase in product demand.

Furthermore, as a part of these efforts, the government collaborated with private companies to distribute oxygen concentrators and set up oxygen supply centers across the country, particularly in regions with high rates of chronic respiratory conditions. For instance, in 2023, the Ministry of Health reported a 25% increase in the distribution of oxygen concentrators in public hospitals, underscoring the impact of such initiatives on the market. Such favorable governmental support is expected to continue driving the growth of oxygen concentrators in the country as part of a broader strategy to enhance healthcare delivery and manage respiratory diseases more effectively.
 

LATAM Medical Oxygen Concentrators Market Trends

The market is experiencing several market trends that are shaping its growth and development. Factors such as growing demand for portable and lightweight oxygen concentrators, expansion of home healthcare services, and rising adoption of telemedicine and remote monitoring, among other factors are boosting the industry growth.
 

• Further, there is a growing need for portable oxygen concentrators (POCs) in the region, particularly for home and travel use. Lightweight, battery-operated models offer greater mobility, enabling patients to maintain an active lifestyle while managing respiratory conditions. This trend aligns with the region’s increasing demand for user-friendly, flexible healthcare solutions.
   
• Additionally, the countries in LATAM are increasingly fostering local manufacturing capabilities to reduce reliance on imports and address supply shortages. Local production initiatives are improving the availability and affordability of oxygen concentrators, particularly for public health facilities, making respiratory care more accessible across the region, thereby aforementioned factors are expected to drive the market.
   

LATAM Medical Oxygen Concentrators Market Analysis

Based on products, the market is segmented into portable and fixed. The portable segment held majority revenue share and was valued at USD 54.8 million in 2023.
 

• The growing emphasis on maintaining mobility and an active lifestyle among patients with chronic respiratory conditions is a key factor driving the demand for portable medical oxygen concentrators in the region.
   
• Unlike traditional fixed oxygen concentrators, portable units allow patients to continue their daily activities, including work, travel, and social engagements, without being confined to their homes. This enhanced freedom and flexibility are crucial for improving the quality of life for individuals who rely on oxygen therapy.
   
• Moreover, the convenience of carrying a lightweight, compact oxygen concentrator that can operate on batteries allows such patients to remain mobile and independent, which is increasingly becoming a priority in managing chronic respiratory conditions. Further, as awareness of these benefits spreads, the demand for portable oxygen concentrators is expected to rise, particularly among those who do not want their condition to limit their lifestyle.
   

Based on application, the LATAM medical oxygen concentrators market is segmented into home care and non-homecare. The home care segment held leading revenue share in the market accounting for USD 53.3 million in 2023.
 

• The preference for home-based care among patients with chronic respiratory conditions is driven by several benefits including comfort and convenience for the user. Managing chronic illnesses at home allows patients to stay in a familiar and supportive environment, which can significantly enhance their overall well-being and mental health. This personalized care approach reduces the stress and discomfort associated with frequent hospital visits or extended stays in clinical settings.
   
• Moreover, home care settings allow patients to maintain their daily routines and social interactions, fostering a sense of normalcy despite their medical needs. This ease of access to treatment, combined with the ability to stay close to family and loved ones, makes home-based care a highly convenient option, further fueling the growth of the home care segment in the medical oxygen concentrators market in the region.
   

Based on technology, the LATAM medical oxygen concentrators market is segmented into continuous flow and fixed flow. The continuous flow segment held majority revenue in 2023 and is anticipated to reach USD 90.5 million by 2032.
 

• Continuous flow oxygen concentrators are commonly used for a wide range of patient groups, including those with severe respiratory conditions, making them a prevalent choice in both home and clinical settings. These concentrators are designed to provide a constant, uninterrupted stream of oxygen.
   
• This steady delivery is crucial for patients with chronic respiratory conditions such as severe chronic obstructive pulmonary disease (COPD), emphysema, and advanced pulmonary fibrosis. These patients often require a consistent and high level of oxygen to manage their symptoms effectively and to maintain their quality of life.
   
• For individuals with severe respiratory disorders, intermittent or pulse flow devices might not meet their oxygen needs adequately. Continuous flow devices ensure that patients receive a continuous and reliable supply of oxygen, which is essential for managing their condition and avoiding hypoxemia (low blood oxygen levels). This is anticipated to drive the segmental growth in the market.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the LATAM medical oxygen concentrators market is segmented into home-care settings, hospitals, ambulatory surgical centers, clinics, and other end users. The home-care settings segment held dominating revenue in the market and was valued at USD 53.3 million in 2023.
 

• A key driver is the growing trend towards home-based healthcare, fueled by increasing healthcare costs and the strain on hospital resources. Patients and healthcare providers are increasingly favoring home care as a cost-effective and convenient alternative to prolonged hospital stays, particularly for chronic respiratory conditions.
   
• The rise in chronic diseases such as chronic obstructive pulmonary disease (COPD) and cardiovascular disorders is another critical factor, as these conditions often require long-term oxygen therapy that can be effectively managed at home. This trend is supported by advancements in telemedicine and remote monitoring technologies, which enable healthcare professionals to oversee patients' oxygen therapy from a distance, ensuring continuity of care.
   
• Moreover, increased awareness campaigns about the benefits of home oxygen therapy and the availability of government subsidies and insurance coverage for home care equipment are encouraging the adoption of medical oxygen concentrators in home settings across the region.
   

The Brazil medical oxygen concentrators market is estimated to witness significant growth during the forecast period to reach USD 63.7 million by 2032.
 

• The Brazilian government's commitment to expanding access to healthcare has led to increased investments in respiratory care. For instance, in 2021, the Brazilian Ministry of Health allocated approximately USD 570 million for the purchase and distribution of medical supplies, including oxygen concentrators, to enhance the country's capacity to respond to and improve infrastructure for respiratory health challenges.
   
• Such investment in healthcare infrastructure and equipment by the government ensures that more patients, particularly those in underserved or remote areas, have access to life-saving oxygen therapy.
   
• Moreover, urbanization has resulted in the expansion of healthcare facilities in cities, with an emphasis on equipping hospitals and clinics with advanced medical equipment to cater to the growing urban population. This trend has further boosted the demand for medical oxygen concentrators in Brazil’s urban centers, as healthcare providers seek to offer comprehensive respiratory care services. The concentration of healthcare infrastructure in urban areas also means that residents have better access to these devices, driving their adoption.
   

Mexico medical oxygen concentrators market is anticipated to grow with a healthy 6.4% CAGR during the forecast period.
 

• Mexico has been making significant investments in healthcare infrastructure, particularly in underserved rural areas. The Mexican government has prioritized the expansion and modernization of healthcare facilities to ensure that even remote communities have access to essential medical services. This development includes the distribution of medical oxygen concentrators to rural hospitals and clinics as part of efforts to improve respiratory care across the country.
   
• Furthermore, the country's growing healthcare insurance coverage and public health programs also drive the demand for medical oxygen concentrators. Increased access to health insurance means more people can afford advanced medical treatments, including oxygen therapy.
   
• Public health initiatives aimed at managing chronic respiratory diseases are also contributing to higher adoption rates of oxygen concentrators, as these programs often include subsidies or direct support for acquiring necessary medical equipment.
   

Argentina medical oxygen concentrators market is projected to record substantial growth with the CAGR of 5.9% during the forecast period.
 

• As the private healthcare sector expands, it often leads to increased competition and improved service offerings, including more accessible and affordable oxygen concentrators. Private health facilities frequently offer a wider range of services and products, making advanced medical equipment more readily available to patients who can afford private healthcare options. For instance, according to a 2023 report by the Argentine Private Healthcare Association, the availability of advanced medical devices has increased by 18% in private institutions compared to public ones.
   
• Additionally, private healthcare providers in Argentina emphasize personalized and high-quality patient care, which drives the demand for specialized equipment such as oxygen concentrators. Private hospitals and clinics are better equipped to cater to individual patient needs with tailored solutions, including advanced respiratory care technologies.
   

LATAM Medical Oxygen Concentrators Market Share

The market is highly fragmented, with prominent players like Koninklijke Philips N.V., Inogen, Drive DeVilbiss Healthcare, and CAIRE launching new, technologically advanced products to strengthen their positions. Key players actively engage in collaborations, acquisitions, and product development, fostering innovation and expanding market reach. For instance, Drive DeVilbiss Healthcare, in partnership with Sanrai International, recently launched the PulmO2 10L and 1060AW concentrators tailored for clinical use in resource-limited settings. Additionally, Air Liquide’s USD 850 million investment in a low-carbon oxygen production facility reflects the market’s growth momentum and commitment to advanced oxygen solutions.
 

LATAM Medical Oxygen Concentrators Market Companies

Prominent players operating in the LATAM medical oxygen concentrators industry include:

• Drive DeVilbiss Healthcare
• GCE Group
• Inogen
• Jiangsu Yuyue Medical Equipment & Supply
• Koninklijke Philips
• Nareena Lifesciences
• Niterra
• Sysmed
• Teijin
   

LATAM Medical Oxygen Concentrators Industry News:

• In March 2024, Drive DeVilbiss Healthcare, in collaboration with Sanrai International, unveiled the PulmO2 10L Oxygen Concentrator. This new generation of oxygen concentrator is specifically designed to be energy-efficient, resilient, and suitable for clinical environments, particularly in low-resource settings. This launch is expected to drive both the company’s customer base and their reputation in the market.
   
• In September 2023, Inogen, Inc. successfully completed the acquisition of Physio-Assist SAS, a French company known for its innovative airway clearance technology. This acquisition expanded Inogen's respiratory product portfolio and generated increased customer base for the company.
   

The Latin America medical oxygen concentrators market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Portable
• Fixed

Market, By Application

• Home care
• Non-homecare

Market, By Technology

• Continuous flow
• Fixed flow

Market, By End Use

• Home-care settings
• Hospitals
• Ambulatory surgical centers
• Clinics
• Other end users

The above information is provided for the following countries:

• Brazil
  • Southeast
  • Northeast
  • South
  • Central-West
  • North
• Mexico
• Argentina
• Peru